[Biomarkers in rheumatoid arthritis]

Reumatol Clin. 2011 Mar:6S3:S25-8. doi: 10.1016/j.reuma.2010.10.007. Epub 2011 Mar 5.
[Article in Spanish]

Abstract

The search for biomarkers in rheumatoid arthritis (RA) has been the object of interesting research in the past few years, although results have not always been relevant. Several biomarkers, from several different locations (blood, urine, synovial fluid, synovial tissue) and of different nature (autoantibodies, genetic markers, joint remodeling markers), and related to different outcomes, diagnostic and prognostic markers (joint destruction, disability, lack of remission, mortality, response to anti-rheumatic treatment, etc.) have been studied. The present article reviews research only on soluble biomarkers, mainly those in serum, related to the diagnosis and joint destruction in RA.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antibody Specificity
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / metabolism*
  • Arthritis, Rheumatoid / pathology
  • Autoantibodies / analysis
  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Biomarkers / analysis*
  • Body Fluids / chemistry
  • Citrulline
  • Humans
  • Joints / pathology
  • Peptides / immunology
  • Prognosis
  • Sensitivity and Specificity
  • Treatment Outcome

Substances

  • Autoantibodies
  • Autoantigens
  • Biomarkers
  • Peptides
  • Citrulline